PT861837E - Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents

Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem

Info

Publication number
PT861837E
PT861837E PT98400469T PT98400469T PT861837E PT 861837 E PT861837 E PT 861837E PT 98400469 T PT98400469 T PT 98400469T PT 98400469 T PT98400469 T PT 98400469T PT 861837 E PT861837 E PT 861837E
Authority
PT
Portugal
Prior art keywords
alkyl
amino
novel
preparation
same
Prior art date
Application number
PT98400469T
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Louis Peglion
Mark Millan
Alain Gobert
Bertrand Goument
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PT861837E publication Critical patent/PT861837E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98400469T 1997-02-27 1998-02-27 Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem PT861837E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PT861837E true PT861837E (pt) 2004-07-30

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98400469T PT861837E (pt) 1997-02-27 1998-02-27 Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem

Country Status (18)

Country Link
US (1) US5968954A (enExample)
EP (1) EP0861837B1 (enExample)
JP (1) JPH10237071A (enExample)
CN (1) CN1090627C (enExample)
AT (1) ATE265451T1 (enExample)
AU (1) AU725756B2 (enExample)
BR (1) BR9800763A (enExample)
CA (1) CA2231025C (enExample)
DE (1) DE69823411T2 (enExample)
DK (1) DK0861837T3 (enExample)
ES (1) ES2219853T3 (enExample)
FR (1) FR2760014B1 (enExample)
HU (1) HU224312B1 (enExample)
NO (1) NO314307B1 (enExample)
NZ (1) NZ329853A (enExample)
PL (1) PL190240B1 (enExample)
PT (1) PT861837E (enExample)
ZA (1) ZA981680B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI274750B (en) * 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
CA2587749A1 (en) * 2004-12-08 2006-06-15 Astellas Pharma Inc. Piperidine derivative and process for producing the same
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
NO314307B1 (no) 2003-03-03
HK1014945A1 (en) 1999-10-08
NO980803D0 (no) 1998-02-26
JPH10237071A (ja) 1998-09-08
HU224312B1 (hu) 2005-07-28
HUP9800422A1 (hu) 1999-12-28
ZA981680B (en) 1998-09-04
CA2231025C (fr) 2003-09-16
FR2760014A1 (fr) 1998-08-28
FR2760014B1 (fr) 1999-04-09
CN1090627C (zh) 2002-09-11
PL324982A1 (en) 1998-08-31
NZ329853A (en) 1999-01-28
DE69823411D1 (de) 2004-06-03
CA2231025A1 (fr) 1998-08-27
NO980803L (no) 1998-08-28
ATE265451T1 (de) 2004-05-15
ES2219853T3 (es) 2004-12-01
US5968954A (en) 1999-10-19
AU5635998A (en) 1998-09-03
DE69823411T2 (de) 2005-02-17
EP0861837A1 (fr) 1998-09-02
CN1194983A (zh) 1998-10-07
PL190240B1 (pl) 2005-11-30
HU9800422D0 (en) 1998-04-28
EP0861837B1 (fr) 2004-04-28
BR9800763A (pt) 1999-12-07
DK0861837T3 (da) 2004-08-16
AU725756B2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
BR9812653A (pt) Derivados de carboxamidotiazóis, sua preparação, as composições farmacêuticas que os contêm
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
PT95281A (pt) Processo para a preparacao de derivados de 4-benzoil-isoxazol e de composicoes herbicidas que os contem
MX9204137A (es) Derivados de 5-aril-isoxazol, composicion herbicida que los contiene y procedimiento para su preparacion.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2091834T3 (es) Compuestos aromaticos.
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
AR016134A1 (es) Compuestos derivados de propil-amida o butil-indanilo, composicion farmaceutica que los contiene y su uso para la fabricacion de un medicamento con metalo-proteinasas inhibidoras de la agrecanasa y matriz extracelular eficaz en el tratamiento de la artritis
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
PT1078928E (pt) Derivados da piridina processo para a sua preparacao e as composicoes farmaceuticas que os contem
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
AU5635998A (en) New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them
PT96226A (pt) Processo para a preparacao de derivados morfolinilicos de doxorubicina e de composicoes farmaceuticas que os contem
AR010899A1 (es) Oxazolidinonas, un procedimiento para su preparacion, el empleo de las mismas para preparar un medicamento, medicamentos y preparaciones farmaceuticasque las contienen y un procedimiento para obtener estas preparaciones farmaceuticas.
PT937043E (pt) Novos derivados tetra-hidropiridinicos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
DK0516350T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
PT1010693E (pt) Novos compostos imidazolinicos processo para a sua preparacao e as composicoes farmaceuticas que os contem
AU5473596A (en) New indole, indazole benzisoxazole compounds, their process of preparation and the pharmaceutical compositions which contain them
AR005549A1 (es) Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.
PT92189A (pt) Processo para a preparacao de derivados de difenilacetamidas e de composicoes farmaceuticas que os contem
PT1042326E (pt) Novos derivados da acronicina processo para a sua preparacao e as composicoes farmaceuticas que os contem
RU94036762A (ru) Гетероарилпиперидины, способ их получения, промежуточные соединения синтеза и фармацевтическая композиция
MX9205921A (es) Derivados de bis(fenil)etano, proceso para su preparacion y composicion farmaceutica que los contiene